WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010024108) PROPHYLACTIC OR THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/024108    International Application No.:    PCT/JP2009/064012
Publication Date: 04.03.2010 International Filing Date: 07.08.2009
Chapter 2 Demand Filed:    01.04.2010    
IPC:
C07K 7/08 (2006.01), A61K 38/00 (2006.01), A61K 39/00 (2006.01), A61P 31/16 (2006.01)
Applicants: KEIO UNIVERSITY [JP/JP]; 15-45, Mita 2-chome, Minato-ku, Tokyo 1088345 (JP) (For All Designated States Except US).
SATO, Toshinori [JP/JP]; (JP) (For US Only).
ISHIHARA, Goshi [JP/JP]; (JP) (For US Only)
Inventors: SATO, Toshinori; (JP).
ISHIHARA, Goshi; (JP)
Agent: Saegusa & Partners; Kitahama TNK Building, 1-7-1, Doshomachi, Chuo-ku, Osaka-shi, Osaka 5410045 (JP)
Priority Data:
2008-222062 29.08.2008 JP
Title (EN) PROPHYLACTIC OR THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION
(FR) AGENT PROPHYLACTIQUE OU THÉRAPEUTIQUE DANS L’INFECTION DU VIRUS DE LA GRIPPE
(JA) インフルエンザウイルス感染症の予防ないし治療剤
Abstract: front page image
(EN)Disclosed is a self-assembled product of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. R1-Gly Leu Ala Met Ala Pro Ser Val Gly His Val Arg Gln His Gly-R2 (I) [In the formula, R1 represents a linear or branched acyl group having 14 to 24 carbon atoms; R2 represents OH, NH2, NR3R4, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, or a substituted or unsubstituted aralkyloxy group; and R3 and R4 independently represent a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aralkyl group, an alkoxy group, or a hydroxy group, provided that both R3 and R4 do not represent a hydroxy group or an alkoxy group simultaneously.]
(FR)Cette invention concerne un produit auto-assemblé d’un composé de formule (I) ou son sel pharmaceutiquement acceptable. R1-Gly Leu Ala Met Ala Pro Ser Val Gly His Val Arg Gln His Gly-R2 (I) [Dans la formule, R1 représente un groupe linéaire ou ramifié ayant de 14 à 24 atomes de carbone; R2 représente OH, NH2, NR3R4, un groupe alcoxy substitué ou non substitué, un groupe aryloxy substitué ou non substitué, ou un groupe aralkyloxy substitué ou non substitué; et R3 et R4 représentent indépendamment un groupe alkyle substitué ou non substitué, un groupe aryle substitué ou non substitué, un groupe aralkyle substitué ou non substitué, un groupe alcoxy, ou un groupe hydroxy, dans la mesure où R3 et R4 ne représentent pas un groupe hydroxy ou un groupe alcoxy simultanément.]
(JA) 本発明は、式I: (式中、R1は炭素数14~24の直鎖又は分岐を有するアシル基を示す。R2はOH、NH2、NR34、置換または非置換のアルコキシ基、置換または非置換のアリールオキシ基、置換または非置換のアラルキルオキシ基を示す。R3,R4は同一または異なって、置換または非置換のアルキル基、置換または非置換のアリール基、置換または非置換のアラルキル基、アルコキシ基、水酸基が挙げられる。ただし、R3とR4は同時に水酸基、アルコキシ基となることはない。) で示される化合物又はその薬学的に許容される塩の自己集合体を提供する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)